Derm-it Trotter! Don't Swear About Skincare.

In this episode, we talk about the psychology of tanning. I’m joined by Sherry Pogato, a licensed clinical psychologist, professor, and social media researcher at the University of Connecticut, to break down why indoor tanning and outdoor sunbathing can feel so rewarding – and why melanoma risk warnings barely register. We get into the real drivers: appearance motivation, social rewards, stress relief, and the immediate “feel good” effects people report after UV exposure.

We also zoom out to tanning culture and access. As laws restrict minors in tanning salons, tanning beds don’t just vanish, they pop up in gyms, off-campus student apartments, and even through systems that let students pay with campus cash cards, creating mixed messages about safety. Sherry shares research showing how simple policy changes can reduce availability, and why “make it less easy to tan” can be more effective than another poster full of statistics.

Then we tackle the modern accelerant: social media. From the “natural glow” health halo to TikTok’s visual economy and the rise of "tanmaxing," UV exposure is getting repackaged as wellness and aesthetics. Sherry also explains a promising sun safety intervention that flips the script by recruiting tanners to create and share healthy skin content, shifting behavior through cognitive dissonance instead of preaching. If you care about sun safety, skin cancer prevention, sunscreen habits, or how to change health behavior in a world of algorithms, this one is for you. Subscribe, share with a friend who loves a tan, and leave a review with your biggest question about tanning and UV risk.

“Off-label” can sound like a red flag, but in dermatology it’s often the most practical way to treat real people with real problems. Dr. Trotter sits down with board-certified dermatologist Dr. Victoria Farley to explain what FDA approval actually means, why many effective skin treatments never get a specific label, and how we talk through safety, side effects, and expectations – so patients feel confident rather than confused.

We walk through concrete examples you may recognize from your own care: spironolactone for hormonal acne and androgen-related conditions, finasteride and dutasteride considerations for women, and why low-dose oral minoxidil can be a game-changer when topical routines are hard to keep up with. We also cover a classic “wait, why does my prescription mention cancer?” moment with topical 5-FU, and how that same medication can be used off label for stubborn plantar warts with thoughtful counseling and monitoring.

From there, we zoom out to what’s next in medical dermatology: GLP-1 drugs and their emerging connection to inflammatory skin disease like psoriasis and hidradenitis suppurativa, plus the rapidly expanding world of JAK inhibitors for immune-mediated conditions including lichen planus, lichen sclerosus, granuloma annulare, and more. We also dig into chronic itch, especially in older adults, and why antihistamines are not always the best long-term answer, with off-label options like naltrexone and gabapentin entering the conversation.

If you’ve ever wondered whether off-label prescribing is legal, ethical, or worth it, this conversation gives you a clear framework: evidence, experience, and a patient-specific risk-benefit plan, plus the reality of insurance coverage and prior authorizations. Subscribe for more practical dermatology education, share this with a friend who’s navigating a confusing prescription, and leave a review with the off-label question you want answered next.

DISCLAIMER: The views and opinions expressed in the Derm-it Trotter! podcast are those of the host and guests and do not necessarily reflect the views or positions of the guests’ or host’s institution or employers. The Derm-it Trotter! Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

Your hair can feel like a small thing until cancer treatment threatens to take it away. We sit down with board-certified hematologist-oncologist Dr. Tiffany Pompa to talk honestly about chemotherapy hair loss, why it happens, and why the emotional impact is often underestimated by everyone except the people living it. We also dig into how immunotherapy differs, why hair loss is usually uncommon with many immunotherapy regimens in real practice, and where the published numbers can be confusing without context.

From there, we get practical about scalp cooling and cold cap therapy: who benefits most, when to start, and what to expect on infusion days. Dr. Pompa explains why taxane chemotherapy such as paclitaxel and docetaxel is a common setting for scalp cooling, especially in breast cancer, gynecologic cancers like ovarian cancer, and lung cancer. We walk through the three FDA-approved systems DigniCap, Paxman, and AMA, including the real-life routine of wearing the cap before, during, and after treatment, plus the most common side effects like headaches, intense cold, and rare frostbite.

Access matters as much as science, so we talk insurance coverage, cost, and advocacy. Dr. Pompa shares how she argues medical necessity, why NCCN guidelines help, what Medicare and Medicaid approval in 2026 changes, and how state legislation can expand coverage. We also discuss manual frozen gel cap options like Penguin caps for patients who need a more affordable workaround, along with the tradeoffs. If you or someone you love is starting chemo, this conversation gives you language, options, and a clear next step: ask early. Subscribe, share this with someone who needs it, and leave a review so more patients and clinicians learn that hair loss prevention is part of quality cancer care.

Dark spots can be frustrating, especially when they seem to stick around despite your best efforts. Dr. Heather Woolery-Lloyd joins us to break down what causes hyperpigmentation, the differences between melasma, post-inflammatory hyperpigmentation, and sunspots, and how dermatologists approach treatment.
We discuss the role of sunscreen, visible light, hydroquinone alternatives, chemical peels, and evidence-based skincare ingredients that can help fade discoloration. If you're tired of guessing what works, this episode offers a practical roadmap to treating hyperpigmentation more effectively.

You can feel the tension the moment a patient says, “I want that medication.” From SkinTok trends to viral skincare advice, dermatologist Dr. Jim Del Rosso joins us from the AOCD meeting to break down how dermatologists navigate treatment requests while still building trust. We talk about acne, rosacea, topical steroid fears, antibiotic resistance, and why the right diagnosis matters more than chasing internet trends.
We also unpack the communication skills that actually improve outcomes, from setting realistic skincare timelines to explaining systemic treatments for eczema in a less intimidating way. If you’ve ever felt overwhelmed by conflicting skincare advice or frustrated that products are not working fast enough, this episode brings the focus back to evidence-based care that actually works.